Histone deacetylase and tubulin deacetylase inhibitors

Details for Australian Patent Application No. 2007248656 (hide)

Owner The President and Fellows of Harvard College

Inventors Kwiatkowski, Nicholas Paul; Bradner, James Elliott; Mazitschek, Ralph

Agent Davies Collison Cave

Pub. Number AU-A-2007248656

PCT Pub. Number WO2007/130429

Priority 60/797,211 03.05.06 US

Filing date 2 May 2007

Wipo publication date 15 November 2007

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/357 (1970.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/47 (2006.01) - Quinolines

C07D 215/00 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/00 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 263/00 (1970.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 403/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/00 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/00 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/130429 Priority application(s): WO2007/130429

29 October 2009 Amendment Made

  The nature of the amendment is: Amend applicant name from The President and Fellows of Harvard College to President and Fellows of Harvard College and Dana-Farber Cancer Institute, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007248657-Methods and compositions for remediation of disc herniation by modifying structure

2007248654-Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine